Latest Breaking News On - Professor peter bauer - Page 1 : comparemela.com

Results from pivotal study published in Diagnostics journalConfirmation of utility of lyso-Gb1 (glucosylsphingosine) as a sensitive biomarker for Gaucher diseaseCould predict clinical course of patients and improve personalized care CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 01, 2023 (GLOBE NEWSWIRE) CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced data confirming the

Peter bauerUnited kingdomLennart streibelMelissa hallDrug administrationExchange commissionCorporate communicationsProfessor peter bauerClinical neurogeneticsNewborn screeningInsight reportsGaucher diseaseNeurodegenerative diseasesAucher patientsDisease severityCentogene biodatabank